Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00118222 · ClinicalTrials.gov registry record · Phase 3
High Light and Low Light Dose PDT in Glioma
A Phase 3 study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 1
- Enrollment target
NCT00118222: Completed Phase 3 study, sponsored by Case Comprehensive Cancer Center.
NCT00118222 is a Phase 3 study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 1 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00118222, a Phase 3 study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1 participants
- Enrollment target
Study Summary
RATIONALE: Photodynamic therapy uses a drug, such as porfimer sodium, that becomes active when it is exposed to a certain kind of light. When the drug is active, tumor cells are killed. Giving photodynamic therapy after surgery may kill any remaining tumor cells. PURPOSE: This randomized clinical trial is studying two different light doses of photodynamic therapy using porfimer sodium to compare how well they work in treating patients who are undergoing surgery for recurrent malignant astrocytoma.
Interventions
- PROCEDURE conventional surgery
- PROCEDURE adjuvant therapy
- DRUG porfimer sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2005-03 |
| Est. Completion | 2006-03 |
| Phase | Phase 3 |
What the finished NCT00118222 record still lists
NCT00118222 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which conventional surgery is the first listed.
NCT00118222 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00118222 about?
NCT00118222 is a clinical study titled "High Light and Low Light Dose PDT in Glioma". RATIONALE: Photodynamic therapy uses a drug, such as porfimer sodium, that becomes active when it is exposed to a certain kind of light. When the drug is active, tumor cells are killed. Giving photodynamic therapy after surgery may kill any remaining tumor cells. PURPOSE: This randomized clinical t...
What is the current status of trial NCT00118222?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1 participants. The study started on 2005-03. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00118222?
The interventions under investigation include: conventional surgery (PROCEDURE), adjuvant therapy (PROCEDURE), porfimer sodium (DRUG).
Who is sponsoring clinical trial NCT00118222?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00118222's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia